Pazopanib Impurity 2 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

N,2,3-Trimethyl-N-(2-((4-methyl-3-sulfamoylphenyl)amino)pyrimidin-4-yl)-2H-indazol-6-amine oxide is an impurity of Pazopanib (P210925) which is an oral angiogenesis inhibitor targeting VEGFR and PDGFR.

Pazopanib Impurity 2 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Pazopanib Impurity 2 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Standardpharm Co. Ltd.	86-714-3992388	overseasales1@yongstandards.com	United States	14332	58
BOC Sciences	1-631-485-4226; 16314854226	info@bocsci.com	United States	14055	65
ChemStrong Scientific Co.,Ltd	0755-0755-66853366 13670046396	sales@chem-strong.com	China	18070	56
Guangzhou Dreampharm Biotechnology Co., Ltd.	020-36607679 17825480238	3008233746@qq.com	China	9919	12
Jinan blalong chemical co. LTD	2710913286@.com	1513643261@qq.com	China	14246	58
Cato Research Chemicals Inc.	020-81215950 4000-868-328	customer@uwalab.com	United States	10404	58
Hubei Xinyang Medical Technology Co., Ltd	15347293736 15347293736	2853117764@qq.com	China	8611	58
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd	18502726233; 18502726233	3641133981@qq.com	China	9713	58
Nantong Hanfang Biotechnology Co. , Ltd.	18616537568	hanfangpharma@126.com	China	29981	58

---

• 4-Methyloxidoamino Pazopanib
• N,2,3-Trimethyl-N-(2-((4-methyl-3-sulfamoylphenyl)amino)pyrimidin-4-yl)-2H-indazol-6-amine Oxide
• Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methyloxidoamino]-2-pyrimidinyl]amino]-2-methyl-
• 1821666-73-2